Corporate governance structure for start-ups should identify roles, authority, and timing in key business decisions between shareholders, directors, and the CEO. But if there is a lack of governance structure across the business it could have a negative impact on the success of the company. For instance it could be much harder to attract funding from investors.
In this expert class the importance of a governance structure will be addressed. What are the criteria for a strong governance structure and what are the roles of the CEO, management team and board members. Also the planning and timeline for the evolution of the governance at different stages of the company will be discussed. This topic will be addressed from different perspectives and speakers including entrepreneurs, investors and experienced board members.
The expert class program is set up in an interactive way such that the participants have also the possibility to bring their own questions and discuss issues they encounter in their own (start-up) company and/or business case. The expert class will also give the possibility to broaden the participants network.
Date: February 24, 2022
Venue: Loyens & Loeff, Amsterdam
13.00 hrs. Welcome by Chrétien Herben (moderator)
13.30 hrs. Start Expert Class
Pitch participants (2 min. per participant):
- Company presentation and/or business case
- Share questions and/or issues on the topic
14.00 hrs. Speaker to be announced
14.00 hrs. Dinko Valerio, scientist-turned-entrepreneur
Domenico (Dinko) Valerio is a scientist-turned-entrepreneur, co-founder and Executive Chairman of Leyden Labs, a company targeting commonalities of respiratory viruses to protect against known and future viral outbreaks. He is also the founder and former CEO of Crucell, a biotechnology company specializing in vaccines. He further co-founded Galapagos Genomics and Venture Capital firm Aescap Venture. As a mentor of other entrepreneurs, Dinko co-founded ProQR Therapeutics (PRQR) where he is Chairman of the Board.
In 1992, Dinko was appointed professor of gene therapy at the University of Leiden, where he also received his Ph.D. with honours.
15.00 hrs. Dr. Arjen van Tunen, CEO KeyGene
Dr. Arjen van Tunen graduated as MSc. in Medical Biology in 1986 and as PhD in Genetics in 1991, both from the Free University of Amsterdam.
He worked 10 years for the Wageningen based WUR institute Plant Research International. First as Group leader Molecular genetics of floral organ formation in flowers (1991-1995), then as Head of department Cell Biology (1995-1998) and finally as Director Research (1998-2001). In 2001 he became Director of the Swammerdam Institute for Life Science of the University of Amsterdam. In 2004 he joined KeyGene, Wageningen, the Netherlands as CEO.
Among other side functions Arjen is Board Member of EuropaBio and Food Valley NL.
16.00 hrs. Dieuwke Hooft Graafland, attorney at law healthcare and Dries Fransen van de Putte, attorney at law and senior associate at Loyens & Loeff
As a leading firm, Loyens & Loeff is the logical choice for a legal and tax partner if you do business in or from the Netherlands, Belgium, Luxembourg and Switzerland, our home markets. Thanks to our full-service practice, specific sector experience and thorough understanding of the market, our advisers comprehend exactly what you need.
16.45 hrs. Discuss questions and issues from participants with the experts
17.15 hrs. Drinks, bites and networking!
18.00 hrs. End of Expert Class
LifeSciences@Work Expert Classes are a series of targeted (virtual) workshops organized in close collaboration with industry and academic experts
- The small-scale and personalized Expert Classes welcome Venture Challenge Alumni, Value Centre Alumni and NWO Take off Alumni.
- New early startups not (yet) part of our LS@W community but interested to join are also very welcome, provided there is a match with the LS@W community profile.
- Participation is free-of-charge for startup teams.
Registration is needed to attend!
Please send an e-mail to miranda.de.regt@iventus.nl to receive your confirmation and additional final information.
This meeting is powered by Health~Holland